Prosecution Insights
Last updated: October 02, 2026

Case Western Reserve University

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

51 pending office actions • 32 art units • 50 examiners • 0 of 51 (0%) have an AI response strategy ready • 53 patents granted in the last 365 days

Analysis

Case Western Reserve University is managing 52 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 52 actions are assigned to 51 distinct examiners, indicating that almost every action has a unique reviewer. The portfolio is distributed across 32 distinct art units, showing significant technical diversity in biotech research. With 32 distinct art units involved, the university's pharmaceutical and biological innovations are being reviewed by a wide array of specialized groups across the 52 pending office actions.

The busiest examiner is MELHUS, BENJAMIN S, who is responsible for 2 pending office actions. The other actions are assigned to the remaining 51 distinct examiners. This means that 51 distinct examiners are providing input on the university's pending matters. For the practitioner, this distribution requires managing many different examiner personalities and art unit cultures. The breadth of 32 distinct art units ensures that the university's innovations are being evaluated by many different specialized teams. Having 2 pending office actions with MELHUS, BENJAMIN S represents the most concentrated point of contact.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

51
Total Pending OAs
38
Non-Final OAs
12
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
1
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (1)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

33
Hard (65%)
18
Medium (35%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other7 (14%)
§103 only10 (20%)
§102 only1 (2%)
Double-patenting + other7 (14%)
Multi-statute (no §101)25 (49%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

23
Life Sciences
45% of docket
2
Information Tech
4% of docket
1
Communications
2% of docket
0
Semiconductors
0% of docket
13
Mechanical / Eng
25% of docket
12
Business / Other
24% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

510 h
Manual time on pending OAs
102 h
Time saved (low, 20%)
178 h
Time saved (mid, 35%)
4.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MELHUS, BENJAMIN S 2 60.4% +44.1%
WONG, EDNA 1 58.4% -19.7%
KIM, KAITLYN EUNJI 1 73.9% +55.8%
SCHAETZLE, KENNEDY 1 83.8% +8.1%
KOWALKOWSKI, FIONA MARGARET 1 100.0% +0.0%
MORAN, EDWARD JOHN 1 41.8% +61.1%
TRUONG, QUANGLONG N 1 78.8% +23.6%
MORALES, JON ERIC C 1 85.4% +10.0%
LEVICKY, WILLIAM J 1 69.4% +29.7%
KATZ, DYLAN MICHAEL 1 86.2% +21.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18901645 SYSTEMS AND METHODS TO ESTIMATE FORCE OF AN INSTRUMENT KATZ, DYLAN MICHAEL 53d overdue
18950244 PATTERNED STIMULATION INTENSITY FOR NEURAL STIMULATION MORALES, JON ERIC C —

Hard Cases (33)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16630271 COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS AUDET, MAURY A 112d overdue
18546648 SUBCUTANEOUS PHOTOBIOMODULATION KUO, JONATHAN T 51d overdue
17331375 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE KREMER, MATTHEW 30d overdue
18517080 COMPOSITIONS AND METHODS OF TREATING USHER SYNDROME III NGUYEN, QUANG 10d overdue
18109406 COMPOSITIONS AND METHODS OF REDUCING SERUM CHOLESTEROL AND PCSK9 WELLS, LAUREN QUINLAN 4d overdue
17992994 PREDICTING RECURRENCE IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC) WITH INTEGRATED RADIOMIC AND PATHOMIC FEATURES NASSER, ROBERT L 30d
17624347 PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY JOHNSON, ALLISON MARIE 34d
18337677 SYSTEMS AND METHODS FOR STIMULATION PARAMETER CONTRAST (SPC) IMAGING WELCH, WILLOW GRACE 54d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18901645 SYSTEMS AND METHODS TO ESTIMATE FORCE OF AN INSTRUMENT KATZ, DYLAN MICHAEL 53d overdue
19084469 MAGNETIC RESONANCE-BASED CATHETER LOCALIZATION KIM, KAITLYN EUNJI —
18878811 SYNTHETIC SUPRACRESTAL DENTAL IMPLANT FIBERS MORAN, EDWARD JOHN —
18967052 MELT PROCESSED VIRAL NANOPARTICLE CONSTRUCTS TRUONG, QUANGLONG N —
18950244 PATTERNED STIMULATION INTENSITY FOR NEURAL STIMULATION MORALES, JON ERIC C —
18914696 VENTRAL SPINAL CORD STIMULATION FOR AT LEAST PARTIAL RESTORATION OF MOTOR FUNCTION LEVICKY, WILLIAM J —
17855530 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE MELHUS, BENJAMIN S —
17855515 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE MELHUS, BENJAMIN S —

Top Art Units

Art UnitApps
3792 3
3791 3
1653 2
1622 2
1658 2
1638 2
1795 1
3797 1
3772 1
3657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19222648 SYSTEM AND METHOD FOR ELECTROCHEMICAL CO2 REDUCTION WONG, EDNA 1795 §103§112 Non-Final OA — Pending May 29, 2025
19084469 MAGNETIC RESONANCE-BASED CATHETER LOCALIZATION KIM, KAITLYN EUNJI 3797 §103§112 Non-Final OA — Pending Mar 19, 2025
19074968 ELECTRICALLY ANESTHETIZING A PERIPHERAL NERVE WITH ON-DEMAND ELECTRICAL NERVE BLOCK FOR CHRONIC PAIN MANAGEMENT SCHAETZLE, KENNEDY — §102§103§112Other Non-Final OA — Pending Mar 10, 2025
18992764 TRANSIENT ELECTRODES AND ASSOCIATED SYSTEMS AND METHODS FOR NEURAL MODULATION AND RECORDING KOWALKOWSKI, FIONA MARGARET 3792 §102§103§112 Non-Final OA — Pending Jan 09, 2025
18878811 SYNTHETIC SUPRACRESTAL DENTAL IMPLANT FIBERS MORAN, EDWARD JOHN 3772 §102§103§112 Non-Final OA — Pending Dec 24, 2024
18967052 MELT PROCESSED VIRAL NANOPARTICLE CONSTRUCTS TRUONG, QUANGLONG N — §103DP Non-Final OA — Pending Dec 03, 2024
18950244 PATTERNED STIMULATION INTENSITY FOR NEURAL STIMULATION MORALES, JON ERIC C — §102Other Non-Final OA — Pending Nov 18, 2024
18914696 VENTRAL SPINAL CORD STIMULATION FOR AT LEAST PARTIAL RESTORATION OF MOTOR FUNCTION LEVICKY, WILLIAM J — §101§102§103§112 Non-Final OA — Pending Oct 14, 2024
18901645 SYSTEMS AND METHODS TO ESTIMATE FORCE OF AN INSTRUMENT KATZ, DYLAN MICHAEL 3657 §103 Final Rejection 53d overdue Pending Sep 30, 2024
18851170 DETECTING AND MEASURING FAST OPTICAL SIGNALS (FOS) FROM ONE OR MORE CORNEAL NERVES FOR MONITORING A PATIENT'S HEALTH AND WELLNESS LANGHALS, RENEE C — §103 Non-Final OA — Pending Sep 26, 2024
18849757 WIRELESS, BATTERYLESS BLOOD PRESSURE SENSOR IMPLANT UCHITEL, EMILY RUTH ABIGAIL — §102§103§112 Non-Final OA — Pending Sep 23, 2024
18835102 BIOSYNTHETIC HEMOSTAT AND USES THEREOF LOVE, TREVOR M 1611 §103 Non-Final OA — Pending Aug 01, 2024
18728949 ISOCITRATE DEHYDROGENASE 1 INHIBITORS AND METHODS OF USE THEREOF ROMERO, KRISTEN WANG — §102§103§112 Non-Final OA — Pending Jul 15, 2024
18721744 TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS LEWOCZKO, EVAN MICHAEL — §102§103DP Non-Final OA — Pending Jun 19, 2024
18716576 SOLID PARTICLES COMPRISING DECELLULARIZED CARDIAC TISSUE EXTRACELLULAR MATRIX AND METHODS FOR MAKING AND USING THE SAME PHAN, DOAN THI-THUC 1613 §102§103§112 Non-Final OA — Pending Jun 05, 2024
18680965 INTACT MASS SPECTROMETRY FOR DIRECT PROTEIN FOOTPRINTING DOSIMETRY USING COVALENT LABELING MUI, CHRISTINE T — §101§102§103§112 Non-Final OA — Pending May 31, 2024
18626999 COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE BOWERS, ERIN M 1653 §103§112 Non-Final OA — Pending Apr 04, 2024
18608354 COMPOSITIONS AND METHODS FOR TREATING TISSUE INJURY COPPINS, JANET L 1628 §103 Final Rejection 25d overdue Pending Mar 18, 2024
18597085 BIPHASIC OSTEOTENDINOUS REPAIR SCAFFOLDS SCOTLAND, REBECCA LYNN 1615 §103§112 Final Rejection 70d Pending Mar 06, 2024
18687441 TREATMENT OF NEURODEGENERATIVE DISEASES WITH HDAC INHIBITORS VAJDA, KRISTIN ANN 1622 §102§112 Non-Final OA — Pending Feb 28, 2024
18687438 METHODS AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES BARRON, SEAN C 1653 §102§103§112 Non-Final OA — Pending Feb 28, 2024
18686729 DEVICES, SYSTEM AND METHODS FOR EXERCISING WITH MUSCLE STIMULATION GHAND, JENNIFER LEIGH-STEWAR 3611 §102§103 Non-Final OA — Pending Feb 26, 2024
18394838 PROCESSES FOR PRODUCING AND REPROCESSING A RECYCLABLE ETHYLENE-VINYL ESTER POLYMER MONTGOMERY, STEPHEN EDWARD — §103§112 Non-Final OA — Pending Dec 22, 2023
18545231 PREDICTING NEO-ADJUVANT CHEMOTHERAPY RESPONSE FROM PRE-TREATMENT BREAST MAGNETIC RESONANCE IMAGING USING ARTIFICIAL INTELLIGENCE AND HER2 STATUS LIU, GUOZHEN 1686 §101§103 Non-Final OA — Pending Dec 19, 2023
18517080 COMPOSITIONS AND METHODS OF TREATING USHER SYNDROME III NGUYEN, QUANG 1631 §103§112 Final Rejection 10d overdue Pending Nov 22, 2023
18561384 PEPTIDE DRUG CONJUGATES SPECIFIC TO FIBRONECTIN ISOTYPES FOR CANCER THERAPY REYNOLDS, FRED H 1658 §103§112DP Non-Final OA — Pending Nov 16, 2023
18283272 METHODS AND COMPOSITIONS FOR ACCELERATING OLIGODENDROCYTE MATURATION VAN BUREN, LAUREN K 1638 §102§103DP Non-Final OA — Pending Sep 21, 2023
18468009 SYSTEMS AND METHODS TO FACILITATE DECISION MAKING FOR UTILITY NETWORKS ROY, SANCHITA — §103§112 Non-Final OA — Pending Sep 15, 2023
18467820 DIRECT RECYCLING AND RECOVERY METHOD OF CATHODE MATERIALS FROM SPENT LITHIUM ION BATTERIES ESSEX, STEPHAN J 1727 §102§103 Non-Final OA — Pending Sep 15, 2023
18367356 BIOACTIVE AGENT SPATIAL PATTERNED BIODEGRADABLE HYDROGELS BURKE, MATTHEW RYAN 1619 §103§112 Non-Final OA — Pending Sep 12, 2023
18456958 SYSTEMS AND METHODS FOR WATER DISTRIBUTION NETWORK LEAKAGE DETECTION AND/OR LOCALIZATION WU, NICHOLAS S 2148 §103 Final Rejection — Pending Aug 28, 2023
18546648 SUBCUTANEOUS PHOTOBIOMODULATION KUO, JONATHAN T 3792 §103§112 Final Rejection 51d overdue Pending Aug 16, 2023
18546680 PERCUTANEOUS PHOTOBIOMODULATION MINCHELLA, ADAM ZACHARY 3794 §103 Non-Final OA — Pending Aug 16, 2023
18264161 SYSTEMS AND METHODS FOR MULTI-REAGENT CHEMICAL LABELING OF BIOLOGICAL MOLECULES COLE, HOUSTON DAVID 1796 §102§103§112 Non-Final OA — Pending Aug 03, 2023
18337677 SYSTEMS AND METHODS FOR STIMULATION PARAMETER CONTRAST (SPC) IMAGING WELCH, WILLOW GRACE 3792 §101§103 Final Rejection 54d Pending Jun 20, 2023
18323553 COMBINATION OF RADIOMIC AND PATHOMIC FEATURES IN THE PREDICTION OF PROGNOSES FOR TUMORS BURKE, TIONNA M 2178 §101§102§103 Non-Final OA — Pending May 25, 2023
18176877 INHIBITION OF URACIL DNA GLYCOSYLASE IN THE OPEN CONFORMATION BURKETT, DANIEL JOHN 1624 §103§112 Non-Final OA — Pending Mar 01, 2023
18109406 COMPOSITIONS AND METHODS OF REDUCING SERUM CHOLESTEROL AND PCSK9 WELLS, LAUREN QUINLAN 1622 §102§103§112 Non-Final OA 4d overdue Pending Feb 14, 2023
18167438 METHODS OF SENSITIZING CANCER TO IMMUNOTHERAPY SHUPE, ELIZABETH A 1643 §103 Final Rejection 67d overdue Pending Feb 10, 2023
18019993 METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER LIU, TRACY 1614 §103 Final Rejection — Pending Feb 06, 2023
17992994 PREDICTING RECURRENCE IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC) WITH INTEGRATED RADIOMIC AND PATHOMIC FEATURES NASSER, ROBERT L 3992 §101 Final Rejection 30d Pending Nov 23, 2022
17910248 TARGETED NANOBUBBLE THERAPY MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 36d overdue Pending Sep 08, 2022
17897278 SYSTEMS AND METHODS FOR OBSTRUCTIVE SLEEP APNEA DETECTION AND MONITORING LEE, MICHELLE J 3786 §101§103 Final Rejection — Pending Aug 29, 2022
17815563 SYSTEMS AND METHODS FOR DATA ANALYTICS FOR VIRTUAL ENERGY AUDITS AND VALUE CAPTURE ASSESSMENT OF BUILDINGS SINGLETARY, TYRONE E 3625 §103 Non-Final OA — Pending Jul 27, 2022
17855530 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE MELHUS, BENJAMIN S 3791 §103DP Non-Final OA — Pending Jun 30, 2022
17855515 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE MELHUS, BENJAMIN S 3791 §103DP Non-Final OA — Pending Jun 30, 2022
17661656 MAPPING PERITUMORAL INFILTRATION AND PREDICTION OF RECURRENCE USING MULTI-PARAMETRIC MAGNETIC RESONANCE FINGERPRINTING RADIOMICS NGUYEN, ALLEN H 2683 §101§102§103 Non-Final OA — Pending May 02, 2022
17624347 PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY JOHNSON, ALLISON MARIE 1638 §103§112 Non-Final OA 34d Pending Jan 02, 2022
17612047 Variant Single-Chain Insulin Analogues KONOPELSKI SNAVEL, SARA ELIZABETH 1658 §102§103DP Non-Final OA 10d overdue Pending Nov 17, 2021
17331375 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE KREMER, MATTHEW 3791 §103§112 Non-Final OA 30d overdue Pending May 26, 2021
16630271 COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS AUDET, MAURY A 1654 §103§112 Final Rejection 112d overdue Pending Jan 10, 2020

Managing Case Western Reserve University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month